Combining the diabetes medication metformin and the antihistamine clemastine significantly increased myelin repair in people with relapsing-remitting multiple sclerosis (RRMS), according to results from a Phase 2 clinical trial. However, […]
The post ECTRIMS 2025: Drug combo shows promise for myelin repair in trial appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com